These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 37082398)

  • 1. Status of Universal Drug Susceptibility Testing in Pulmonary Tuberculosis Patients Initiated on Treatment in an Urban Setting, South India.
    Velayutham B; Jayabal L; Watson B; Jagadeesan S; Suresh C; Nair D; Gopalaswamy R; Devaleenal B; Selvaraju S; Padmapriyadarsini C
    Indian J Community Med; 2023; 48(1):103-107. PubMed ID: 37082398
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Status of universal drug-susceptibility testing among sputum smear-positive tuberculosis patients diagnosed at a tertiary care centre.
    Debolina P; Palanivel C; Manju R; Tanveer R
    Indian J Med Res; 2023; 157(2&3):216-219. PubMed ID: 37202940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Uptake of universal drug susceptibility testing among people with TB in a south Indian district: How are we faring?
    Ranganath R; Shewade HD; Bahadur AK; Naik V; Nagaraja SB; Kumar AMV; Peerapur BV; Babu S; Somshekhar N; Singarajipur A
    Trans R Soc Trop Med Hyg; 2022 Jan; 116(1):43-49. PubMed ID: 33823556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of cartridge-based nucleic acid amplification test (CBNAAT) introduction on the detection of pulmonary and extra-pulmonary tuberculosis in Bhubaneswar, Odisha.
    Bal HB; Kar S; Otta S; Kumar S; Samal S; Pattnaik A; Rout SS; Turuk J; Das D; Pati S; Giri S
    Indian J Pathol Microbiol; 2023; 66(4):764-769. PubMed ID: 38084529
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of UDST: A step forward to end TB.
    Kumar Sharma A; Vijay S; Mathur RB; Meena H
    Indian J Tuberc; 2020 Apr; 67(2):213-215. PubMed ID: 32553314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tuberculosis screening in household contacts of pulmonary tuberculosis patients in an urban setting.
    Velayutham B; Jayabal L; Watson B; Jagadeesan S; Angamuthu D; Rebecca P; Devaleenal B; Nair D; Tripathy S; Selvaraju S
    PLoS One; 2020; 15(10):e0240594. PubMed ID: 33057399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of the Xpert MTB/RIF on the detection of pulmonary tuberculosis cases and rifampicin resistance in Shanghai, China.
    Wu Z; Rueda ZV; Li T; Zhang Z; Jiang Y; Sha W; Yu F; Chen J; Pan Q; Shen X; Yuan Z
    BMC Infect Dis; 2020 Feb; 20(1):153. PubMed ID: 32070292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High pre-diagnosis attrition among patients with presumptive MDR-TB: an operational research from Bhopal district, India.
    Shewade HD; Kokane AM; Singh AR; Verma M; Parmar M; Chauhan A; Chahar SS; Tiwari M; Khan SN; Gupta V; Tripathy JP; Nagar M; Singh SK; Mehra PK; Kumar AM
    BMC Health Serv Res; 2017 Apr; 17(1):249. PubMed ID: 28376789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Application of CBNAAT (Xpert MTB/RIF assay) in new smear negative pulmonary tuberculosis patients.
    Chopra V; Singh Virk B; Chopra S; Bansal M; Chungath J
    Monaldi Arch Chest Dis; 2020 Feb; 90(1):. PubMed ID: 32124585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early results of systematic drug susceptibility testing in pulmonary tuberculosis retreatment cases in Cameroon.
    Noeske J; Voelz N; Fon E; Abena Foe JL
    BMC Res Notes; 2012 Mar; 5():160. PubMed ID: 22436423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Revisions in TB programme - boon or bane? A qualitative study exploring barriers and facilitators among health care workers in private and public sector, Kerala.
    Mathew G; Kumar SCS; Cherian KM; Issac N; Benjamin AI
    Indian J Tuberc; 2021 Jul; 68(3):356-362. PubMed ID: 34099201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A prospective study evaluating the impact of cartridge-based nucleic acid amplification test (CBNAAT) on the management of tuberculosis in a low-resource high-burden Indian rural setting.
    Youngs J; Patil S; Jain Y
    J Family Med Prim Care; 2018; 7(5):982-992. PubMed ID: 30598944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Role of Cartridge-Based Nucleic Acid Amplification Test (CBNAAT), Line Probe Assay (LPA), Liquid Culture, Acid-Fast Bacilli (AFB) Smear and Histopathology in the Diagnosis of Osteoarticular Tuberculosis.
    Abhimanyu S; Jain AK; Myneedu VP; Arora VK; Chadha M; Sarin R
    Indian J Orthop; 2021 May; 55(Suppl 1):157-166. PubMed ID: 34122769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recurrence of tuberculosis among newly diagnosed sputum positive pulmonary tuberculosis patients treated under the Revised National Tuberculosis Control Programme, India: A multi-centric prospective study.
    Velayutham B; Chadha VK; Singla N; Narang P; Gangadhar Rao V; Nair S; Ramalingam S; Narayanan Sivaramakrishnan G; Joseph B; Selvaraju S; Shanmugam S; Narang R; Pachikkaran P; Bhat J; Ponnuraja C; Bajaj Bhalla B; Shivashankara BA; Sebastian G; Yadav R; Kumar Sharma R; Sarin R; Myneedu VP; Singla R; Khayyam K; Mrithunjayan SK; Jayasankar SP; Sanker P; Viswanathan K; Viswambharan R; Mathuria K; Bhalla M; Singh N; Tumane KB; Dawale A; Tiwari CP; Bansod R; Jayabal L; Murali L; Khaparde SD; Rao R; Jawahar MS; Natrajan M
    PLoS One; 2018; 13(7):e0200150. PubMed ID: 29979738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of Anaemia and Magnesium Levels at the Initiation of Tuberculosis Therapy with Sputum Conversion among Pulmonary Tuberculosis Patients.
    Agrawal Y; Goyal V; Singh A; Lal S
    J Clin Diagn Res; 2017 Jun; 11(6):BC01-BC04. PubMed ID: 28764146
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contact screening and chemoprophylaxis in India's Revised Tuberculosis Control Programme: a situational analysis.
    Banu Rekha VV; Jagarajamma K; Wares F; Chandrasekaran V; Swaminathan S
    Int J Tuberc Lung Dis; 2009 Dec; 13(12):1507-12. PubMed ID: 19919768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successfully Engaging Private Providers to Improve Diagnosis, Notification, and Treatment of TB and Drug-Resistant TB: The EQUIP Public-Private Model in Chennai, India.
    Ananthakrishnan R; Richardson MD; van den Hof S; Rangaswamy R; Thiagesan R; Auguesteen S; Kamp N
    Glob Health Sci Pract; 2019 Mar; 7(1):41-53. PubMed ID: 30926737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How Do Urban Indian Private Practitioners Diagnose and Treat Tuberculosis? A Cross-Sectional Study in Chennai.
    Bronner Murrison L; Ananthakrishnan R; Sukumar S; Augustine S; Krishnan N; Pai M; Dowdy DW
    PLoS One; 2016; 11(2):e0149862. PubMed ID: 26901165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A study on procedural delay in diagnosis and start of treatment in drug resistant tuberculosis under RNTCP.
    Sharma AK; Gupta N; Verma S; Chandran A; Dixit R
    Indian J Tuberc; 2019 Jul; 66(3):394-401. PubMed ID: 31439186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implementation of the national tuberculosis guidelines on culture and drug sensitivity testing in Guatemala, 2013.
    Samayoa-Peláez M; Ayala N; Yadon ZE; Heldal E
    Rev Panam Salud Publica; 2016 Jan; 39(1):44-50. PubMed ID: 27754536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.